Skip to main content

Table 1 Patient Demographics

From: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy

Variable

Mean ± SD/n (%)

Gender (M/F)

7 (18%)/ 30 (81%)

Age (years)

38.4 ± 11.3

Height (cms)

163.0 ± 8.0

Weight (Kg)

64.0 ± 9.4

BMI (Kg/m2)

23.9 ± 3.0

Disease Duration (years)

3.0 ± 1.0

NYHA functional classification

 Class I

3 (8%)

 Class II

22 (60%)

 Class III

12 (32%)

NT-ProBNP at baseline (pg/ml)

549 ± 562

mPAP (mmHg)

57.0 ± 12.0

Systolic PAP (mmHg)

89 ± 16

Diastolic PAP (mmHg)

37 ± 12

  1. NYHA New York Heart Association, mPAP mean pulmonary arterial pressure